“Nerva helped me rewire my vagus nerve communication. Now my gut talks to my brain in a way that doesn't signal panic. I can cook and eat normally again. I can go to restaurants.”
Mindovermatter.
What the brain does, the body feels. Clinically validated programs for the chronic conditions drugs weren’t built for.
- 350,000+ patients
- 10+ published studies
- 20,000+ referring providers
- 30M+ covered lives
Where current care runs out.
Chronic pain, IBS, menopause, and anxiety affect about one in four adults. Most are already in care. Most still have symptoms. Years of medications, specialists, and elimination diets move the needle a little, and leave most of the burden on patients, the clinicians who treat them, and the systems that pay for the cycle. For these conditions, the body follows the brain. Drugs don’t reach the wiring.
Programs built on techniques that address the nervous system, not just the symptom.

How we think and feel changes how the body functions. Gut motility. Pain perception. Autonomic regulation. For the chronic conditions where pharmacology under-performs, this brain–body axis is the dominant pathology. Behavioral techniques can engage it. We turn them into software. Adapted to each user. Run from a phone. Measured against the same endpoints as a drug trial.
A growing pipeline of conditions.
Each program is built with the academic centre that wrote the original protocol, tested in randomised trials, and run from a phone. Same brain–body approach. Different conditions.
Brain–body techniques at the speed of software.
Validated symptom tracking
The model meets each person where they are. Symptoms, history, goals, signals.
A program shaped to you
Every audio session, lesson and exercise adapts to your progress. No two programs run the same.
Outcomes you can measure
Continuous feedback drives the model, and clinically meaningful improvement, week over week.
Clinically studied outcomes measured against active controls.
of participants experienced clinically significant abdominal pain reduction at 6 weeks, vs. 35% on active control, in a peer-reviewed gut-directed hypnotherapy trial.1
- Published studies10+
- Patients helped350,000+
- Randomised trialsIncluding AJG 2025 flagship